A number of firms have modified their ratings and price targets on shares of Avantor (NYSE: AVTR) recently:
- 7/29/2024 – Avantor had its price target raised by analysts at Morgan Stanley from $28.00 to $29.00. They now have an “overweight” rating on the stock.
- 7/29/2024 – Avantor had its price target raised by analysts at Barclays PLC from $25.00 to $28.00. They now have an “overweight” rating on the stock.
- 7/29/2024 – Avantor had its “outperform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $31.00 price target on the stock.
- 7/29/2024 – Avantor had its price target raised by analysts at Robert W. Baird from $26.00 to $27.00. They now have an “outperform” rating on the stock.
- 7/29/2024 – Avantor had its price target raised by analysts at TD Cowen from $28.00 to $31.00. They now have a “buy” rating on the stock.
- 7/29/2024 – Avantor had its price target raised by analysts at Stifel Nicolaus from $27.00 to $28.00. They now have a “buy” rating on the stock.
- 7/15/2024 – Avantor had its price target raised by analysts at Royal Bank of Canada from $30.00 to $31.00. They now have an “outperform” rating on the stock.
- 7/10/2024 – Avantor was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $23.00 price target on the stock, down previously from $30.00.
- 7/2/2024 – Avantor had its price target lowered by analysts at Evercore ISI from $28.00 to $27.00. They now have an “outperform” rating on the stock.
- 6/28/2024 – Avantor had its price target lowered by analysts at Barclays PLC from $28.00 to $25.00. They now have an “overweight” rating on the stock.
Avantor Stock Performance
AVTR traded down $1.10 on Friday, reaching $25.40. 2,100,001 shares of the stock were exchanged, compared to its average volume of 7,040,287. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. The company’s 50-day moving average price is $22.56 and its 200 day moving average price is $23.76. The firm has a market capitalization of $17.27 billion, a PE ratio of 65.13, a PEG ratio of 2.73 and a beta of 1.32. Avantor, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $28.00.
Insider Transactions at Avantor
In related news, insider Christophe Couturier 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.50% of the company’s stock.
Hedge Funds Weigh In On Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Recommended Stories
- Five stocks we like better than Avantor
- What to Know About Investing in Penny Stocks
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- How to buy stock: A step-by-step guide for beginners
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
- 3 Best Fintech Stocks for a Portfolio Boost
- Chevron Stock Dips as Earnings Miss Highlights Merger Uncertainty
Receive News & Ratings for Avantor Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor Inc and related companies with MarketBeat.com's FREE daily email newsletter.